Corante

About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: derekb.lowe@gmail.com Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Emolecules
ChemSpider
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
PubChem
Not Voodoo
DailyMed
Druglib
Clinicaltrials.gov

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
Kilomentor
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
ChemBark
Realizations in Biostatistics
Chemjobber
Pharmalot
ChemSpider Blog
Pharmagossip
Med-Chemist
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
SimBioSys
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Business|Bytes|Genes|Molecules
Eye on FDA
Chemical Forums
Depth-First
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa


Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
FuturePundit
Aetiology
Gene Expression (I)
Gene Expression (II)
Sciencebase
Pharyngula
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net


Medical Blogs
DB's Medical Rants
Science-Based Medicine
GruntDoc
Respectful Insolence
Diabetes Mine


Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem


Politics / Current Events
Virginia Postrel
Instapundit
Belmont Club
Mickey Kaus


Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Dumpster Diving for Data? | Main | The Journals Fight Back »

June 14, 2004

Wipe Down

Email This Entry

Posted by Derek

Family activities prohibit much blogging tonight, but I wanted to bring up a couple of other issues about secrecy in the drug business. One effect of all the proprietary information running around inside our buildings is that it's rather unusual to have someone from a rival drug firm visit another one. If they do, then it's likely to be for a seminar or symposium, and they'll be confined to the public meeting areas of the site.

The only times you see any people from another company up in the lab areas are when some sort of research deal has been signed, or (more commonly!) when someone is slipping over to interview for a job. Those are certainly the only times I've ever seen the inside of another drug company, and quite right. I wouldn't let me upstairs, either.

It's not like I'm going to be snooping around, but it would be impossible not to see something revealing. There isn't going to be any sensitive information lying around in the cafeteria or the main conference rooms - there had better not be - but there's nothing but sensitive stuff all over the labs: notebooks, spectra, printouts, structures and reactions all over the blackboards and the sliding glass of the fume hoods.

All that can stay up if there's a high school group coming through on a tour. But two or three times in my career, I've been in labs where we had to sanitize the place ahead of scientifically adept outside visitors (a busload of miscellaneous academics, say) and it was a pain. It's odd to look through hood sashes that aren't full of blue and black heiroglyphics for once.

Comments (1) + TrackBacks (0) | Category: Life in the Drug Labs


COMMENTS

1. Dawn B. on June 24, 2004 8:33 PM writes...

Boy do I hear that. My first company had regular wipedowns because we were constantly receiving visitors as we had several third party contracts and were looking for investors. We were encouraged not to write on our hoods in the first place and to keep all spectra/notebooks/etc. at our desks. Was very annoying when I wanted to spread out for some data analysis, only I couldn't because someone *might* walk by.

Dawn

Permalink to Comment


EMAIL THIS ENTRY TO A FRIEND

Email this entry to:

Your email address:

Message (optional):




RELATED ENTRIES
Messed-Up Clinical Studies: A First-Hand Report
Pharma and Ebola
Lilly Steps In for AstraZeneca's Secretase Inhibitor
Update on Alnylam (And the Direction of Things to Come)
There Must Have Been Multiple Chances to Catch This
Weirdly, Tramadol Is Not a Natural Product After All
Thiola, Retrophin, Martin Shkrell, Reddit, and More
The Most Unconscionable Drug Price Hike I Have Yet Seen